INOV - Ticker AI Digest

Schroders Capital Global Innovation Trust plc - INOV 📰 1
Desk Snapshot GO VIP Login
Important AI Risk Notice

Charts, catalyst summaries, AI scores, forecasts and price context are AI-driven and can hallucinate, lag or miss market-changing information.

Not investment advice. Markets can move fast and any trade or allocation decision remains your responsibility.
AI can hallucinate. Summaries, rankings, forecasts and commentary can be wrong, incomplete or misleading.
AI-driven data only. Signals, dates, prices, sentiment and automation outputs may be delayed, estimated or stale.
Always verify externally. Confirm prices, filings, broker notes and trade setup details with independent sources before acting.
Mobile Command Deck
Schroders Capital Global Innovation Trust plc - INOV in one cleaner mobile flow.
Tap straight into the module you want. No sideways tab hunt, just a clean route into charts, news, Today’s AI, and the deeper desks.
INOV Data 2026-03-31 Preview Mode
Core Deck
Deep Dive Modules

Digested News

Today's Catalysts (INOV) 1
INOV 06:01
Schroders Capital Global Innovation Trust plc - INOV
Final Results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Schroders Capital Global Innovation Trust plc (the Company) announced its final results for the year ended 31 December 2025, highlighting its managed wind-down strategy and capital returns to shareholders. Key points include
1. **Managed Wind-Down** Following shareholder approval, the Company focused on an orderly wind-down, realizing portfolio assets while balancing timely returns and value maximization.
2. **Capital Returns**
Completed a £37 million tender offer in July 2025.
Plans a further £18 million tender offer in June 2026, subject to shareholder approval.
3. **Financial Performance**
NAV per share increased by 11.5% to 22.23p.
Share price rose by 38.2% to 15.20p.
Total realisations of £35.9 millionincluding sales of Araris BiotechSecuriti AIand Anthos Therapeutics.
4. **Portfolio Highlights**
Life sciences portfolio drove performance, with Araris sale generating £18.0 million in gains.
Growth portfolio contributed positively, with valuation uplifts for AI Company II and Revolut.
5. **Post-Year Developments**
Received £6.5 million from the sale of Bluewater Bio in January 2026.
No material realisations expected before 2028.
6. **Board and Governance**
Reduced board size to three directors post-wind-down approval.
AGM scheduled for 2 June 2026, with a concurrent General Meeting for tender offer approval.
7. **Outlook**
Focus remains on disciplined asset realisation and liquidity management.
Increased volatility expected as the portfolio becomes more concentrated.
The Company continues to prioritize shareholder returns and transparency during its wind-down phase.
Financial Metric20242025Change
NAV per Share (pence)19.9422.23+11.5%
Total NAV (£'000)162,445141,221-13.1%
Total Realisations (£'000)56,94975,360+32.3%
Cash and Liquid Funds (£'000)29,63518,231-38.5%
Debt (£'000)000%
Share Price (pence)11.0015.20+38.2%
Share Price Discount to NAV (%)44.8%31.6%-29.5%
AI 0
No items for this category on selected date.
Acquisitions 0
No items for this category on selected date.
Agreement 0
No items for this category on selected date.
Approvals 0
No items for this category on selected date.
Authorisation 0
No items for this category on selected date.
Awards 0
No items for this category on selected date.
BTC 0
No items for this category on selected date.
Blockchain 0
No items for this category on selected date.
Breakthrough 0
No items for this category on selected date.
BuyBack 0
No items for this category on selected date.
Cancellations 0
No items for this category on selected date.
CashOffer 0
No items for this category on selected date.
Collaborate 0
No items for this category on selected date.
ContractWin 0
No items for this category on selected date.
Covid-19 0
No items for this category on selected date.
Deals 0
No items for this category on selected date.
Diamond 0
No items for this category on selected date.
DirectorDealing 0
No items for this category on selected date.
Discovery 0
No items for this category on selected date.
Exceeded 0
No items for this category on selected date.
FCA 0
No items for this category on selected date.
FDA 0
No items for this category on selected date.
Grants 0
No items for this category on selected date.
InvestmentPlan 0
No items for this category on selected date.
JV 0
No items for this category on selected date.
Launch 0
No items for this category on selected date.
Litigation 0
No items for this category on selected date.
NewContract 0
No items for this category on selected date.
Offers 0
No items for this category on selected date.
Offtake 0
No items for this category on selected date.
Orders 0
No items for this category on selected date.
Partner 0
No items for this category on selected date.
Patents 0
No items for this category on selected date.
Placing 0
No items for this category on selected date.
Positive 0
No items for this category on selected date.
Proposals 0
No items for this category on selected date.
Reports 0
No items for this category on selected date.
Results 1
INOV 06:01
Schroders Capital Global Innovation Trust plc - INOV
Final Results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Schroders Capital Global Innovation Trust plc (the Company) announced its final results for the year ended 31 December 2025, highlighting its managed wind-down strategy and capital returns to shareholders. Key points include
1. **Managed Wind-Down** Following shareholder approval, the Company focused on an orderly wind-down, realizing portfolio assets while balancing timely returns and value maximization.
2. **Capital Returns**
Completed a £37 million tender offer in July 2025.
Plans a further £18 million tender offer in June 2026, subject to shareholder approval.
3. **Financial Performance**
NAV per share increased by 11.5% to 22.23p.
Share price rose by 38.2% to 15.20p.
Total realisations of £35.9 millionincluding sales of Araris BiotechSecuriti AIand Anthos Therapeutics.
4. **Portfolio Highlights**
Life sciences portfolio drove performance, with Araris sale generating £18.0 million in gains.
Growth portfolio contributed positively, with valuation uplifts for AI Company II and Revolut.
5. **Post-Year Developments**
Received £6.5 million from the sale of Bluewater Bio in January 2026.
No material realisations expected before 2028.
6. **Board and Governance**
Reduced board size to three directors post-wind-down approval.
AGM scheduled for 2 June 2026, with a concurrent General Meeting for tender offer approval.
7. **Outlook**
Focus remains on disciplined asset realisation and liquidity management.
Increased volatility expected as the portfolio becomes more concentrated.
The Company continues to prioritize shareholder returns and transparency during its wind-down phase.
Financial Metric20242025Change
NAV per Share (pence)19.9422.23+11.5%
Total NAV (£'000)162,445141,221-13.1%
Total Realisations (£'000)56,94975,360+32.3%
Cash and Liquid Funds (£'000)29,63518,231-38.5%
Debt (£'000)000%
Share Price (pence)11.0015.20+38.2%
Share Price Discount to NAV (%)44.8%31.6%-29.5%
Significant 0
No items for this category on selected date.
Speculation 0
No items for this category on selected date.
Strategic 0
No items for this category on selected date.
Suspension 0
No items for this category on selected date.
TR1 0
No items for this category on selected date.
Takeover 0
No items for this category on selected date.
Understanding 0
No items for this category on selected date.
Updates 0
No items for this category on selected date.
Vaccine 0
No items for this category on selected date.
Wins 0
No items for this category on selected date.
Worth 0
No items for this category on selected date.
All Market News (Last 30 Days) 1
INOV 06:01
Schroders Capital Global Innovation Trust plc - INOV
Final Results
AI Expand: Explanation + Tables
Return to today’s catalyst cards, chart beacons and AI charts.
**Summary**
Schroders Capital Global Innovation Trust plc (the Company) announced its final results for the year ended 31 December 2025, highlighting its managed wind-down strategy and capital returns to shareholders. Key points include
1. **Managed Wind-Down** Following shareholder approval, the Company focused on an orderly wind-down, realizing portfolio assets while balancing timely returns and value maximization.
2. **Capital Returns**
Completed a £37 million tender offer in July 2025.
Plans a further £18 million tender offer in June 2026, subject to shareholder approval.
3. **Financial Performance**
NAV per share increased by 11.5% to 22.23p.
Share price rose by 38.2% to 15.20p.
Total realisations of £35.9 millionincluding sales of Araris BiotechSecuriti AIand Anthos Therapeutics.
4. **Portfolio Highlights**
Life sciences portfolio drove performance, with Araris sale generating £18.0 million in gains.
Growth portfolio contributed positively, with valuation uplifts for AI Company II and Revolut.
5. **Post-Year Developments**
Received £6.5 million from the sale of Bluewater Bio in January 2026.
No material realisations expected before 2028.
6. **Board and Governance**
Reduced board size to three directors post-wind-down approval.
AGM scheduled for 2 June 2026, with a concurrent General Meeting for tender offer approval.
7. **Outlook**
Focus remains on disciplined asset realisation and liquidity management.
Increased volatility expected as the portfolio becomes more concentrated.
The Company continues to prioritize shareholder returns and transparency during its wind-down phase.
Financial Metric20242025Change
NAV per Share (pence)19.9422.23+11.5%
Total NAV (£'000)162,445141,221-13.1%
Total Realisations (£'000)56,94975,360+32.3%
Cash and Liquid Funds (£'000)29,63518,231-38.5%
Debt (£'000)000%
Share Price (pence)11.0015.20+38.2%
Share Price Discount to NAV (%)44.8%31.6%-29.5%

Today's AI

Today's AI Starts With News

1 live catalyst is opening Today’s AI for INOV.

Start with the live headline tape first. Today’s AI findings sit next, and the AI Blend stack drops lower once the news context is framed. Financial Forecastist now feeds the blend too.
Live Tape Data 2026-03-31 Blend Lower Down
Read the alert tape first, then open Today’s AI findings. Use AI Expand on any card to open the AI explanation, results tables and financial forecast rows instantly.
1 Today
Front Of Desk
Schroders Capital Global Innovation Trust plc - INOV has fresh news flow live now, so Today’s AI is leading with the tape before the blended signal stack below.
Single-Ticker Today's AI
INOV signal theatre built from scored market catalysts, automated AI forecasts, financial forecasting and live trigger logic.

This is the ticker-specific Today’s AI desk for Schroders Capital Global Innovation Trust plc - INOV. It compresses the live catalyst tape, bullish and bearish scoring, AI price forecasts, financial forecasting and trigger logic into one cockpit so users can judge conviction without hopping across screens.

Subscription Required Bullish vs Bearish Scoring AI + Financial Blend Buy / Sell Trigger Engine Today's AI Findings
Create Account Member Login
Subscriber Unlock
Subscribe to unlock the full INOV Today’s AI cockpit.

Subscription turns this tab into a live signal desk with today’s news findings at the top, AI plus financial blend comparisons at the bottom, buy and sell trigger logic, and the full findings ledger behind every scored row.

  • AI-scored market headlines with sentiment buckets and buzzword breakdowns.
  • Forecast leaders ranked by projected gain against current market price.
  • Advanced technical scans, AI forecast stacks, and predictive MACD inside the live stock terminal charts.
  • Single-ticker AI Crunch desks with buy or sell trigger logic and full catalyst ledgers.
  • Scored earnings shock board with predicted direction, sector pulse and catalyst narrative.
  • Fast market scan built for event-driven trading, not passive dashboards.
Subscribe to unlock the ticker-specific Today’s AI stack, sentiment gauges, AI blend stage, and the full findings ledger for INOV on 2026-03-31.

Fundamentals Matrix

Overall Fundamentals
Signal: Pending
Capital Strength
Signal: Pending
Float Liquidity
Signal: Pending
Short Pressure
Signal: Pending
Target Setup
Signal: Pending
Market Profile
Signal: Pending
Market Cap
100.1M
Enterprise Value
-
Public Float
0
Broker Target
-
Shares Out
635.4M
Long Interest
-
Short Interest
-
Exchange
-
Currency Code
-
ISIN
None
Market
None
Sector
Unknown
Float / Shares Ratio
-
Short vs Long Delta
-
EV / Market Cap
-

Financials Matrix

News And Alerts First

1 live alert now opens the financials desk for INOV.

Start with the headline flow and alert tape first. Then drop straight into Financial Forecastist below for the revenue path, EPS shape, cash pressure and balance-sheet read while the catalyst context is still hot.
Live Alerts Data 2026-03-31 Forecastist Below
Read the alert tape first, then move into Financial Forecastist below. Use AI Expand on any catalyst card to open the AI explanation and results tables without losing the ticker context.
1 Alerts
Front Of Desk
Schroders Capital Global Innovation Trust plc - INOV has fresh filing flow live now, so the tape is framing the revenue, leverage and valuation story below.
Overall Stability
Signal: Pending
Profitability
Signal: Pending
Debt & Cash
Signal: Pending
Valuation Risk
Signal: Pending
Forward Expectation
Signal: Pending
Dividend Safety
Signal: Pending
Divi Rate
-
Ex Divi
2016-05-19
Earnings Date
2026-03-26
Net Debt
-
Cash
6.2M
EPS
0.02
Net Income
16.5M
Revenue
17.5M
Enterprise Value
-
Trailing PE
7.875
Forward PE
-
Price Sales TTM
5.385
Price Book MRQ
0.6884
EV Revenue
5.5517
EV EBITDA
-
Financial Forecastist

Mixed financial engine

Run the upgraded fundamentals refresh to populate annual and quarterly financial statement history here.

Statement history loaded
Mixed
Quarter Revenue
-
-
vs prior comparable quarter
Net Margin
-
-
profitability pulse
Free Cash Flow
-
-
cash conversion
Net Debt / EBITDA
-
-
lower is cleaner
Revenue Engine

Quarterly revenue history has not been populated yet.

Profit Stack

Profitability history is not loaded yet.

Balance-Sheet Pressure

Leverage history is not loaded yet.

Quarterly Revenue Runway

Actual revenue bars, consensus revenue where available, plus the terminal model path.

Profit And Cash Conversion

Net income and free cash flow moving together is usually what separates genuine improvement from noise.

Balance-Sheet Pressure

Cash, net debt and liquidity tell us whether the business is strengthening or just surviving.

Annual Power Curve

Longer-cycle revenue and net income help frame whether the company is compounding or rolling over.
FY 2018
Consensus
0
Revenue Path
-
EPS / Earnings
Growth cue -

Quarterly Statement Tape

Last 6 Quarters
Period Revenue Net Income FCF Net Debt
Q4 2025 - - - -
Q4 2024 - - - -
Q2 2024 - - - -

Annual Financial Power

Last 5 Years
Period Revenue Net Income EBITDA FCF
FY 2025 17.5M 16.5M - -1.4M
FY 2024 -48.0M -49.3M - 2.7M
FY 2023 -32.5M -33.8M - -1.4M
FY 2022 -176.9M -178.1M - -2.5M
FY 2021 120.2M 118.8M - -6.2M

Structure DNA

Market Structure DNA

Income Anchor profile with trend mixed

Price is 71.7% through the 52-week range, +3.4% vs 50DMA and +2.5% vs 200DMA. 32.1% of the register is locked by institutions and insiders, leaving 67.9% free float. Capital rhythm reads annual with forward yield near 0.0% and payout around 0.0%.

Trend mixed Institutional gravity Reliable income rhythm As Of 2026-04-19
Income Anchor
Structure Score
61.9 / 100
Income Anchor
Trend Stack
+3.4% / +2.5%
vs 50DMA / 200DMA
52W Position
71.7%
auction position inside the yearly range
Ownership Lock
32.1%
26.5% institutions | 5.6% insiders
Pressure Pocket
67.9% free float
Vendor short-float fields were not supplied
Capital Rhythm
Annual
Yield 0.0% | payout 0.0%
Trend Runway

Implied spot is 14.80 with the stock +3.4% vs 50DMA and +2.5% vs 200DMA. The tape is sitting 71.7% through the 52-week range, which frames the regime as trend mixed.

Ownership Register

Institutions hold about 26.5% and insiders about 5.6%, locking roughly 32.1% of the register and leaving 67.9% in free float. That reads as institutional gravity.

Pressure Pocket

The API did not return a usable short-float field for this ticker, so the pressure score leans more on float lock and crowding than a full short ledger.

Capital Rhythm

Dividend cadence reads annual with 1 event(s) in the last full year, a five-year average of 1.0, and stability score 100.0/100. Forward yield sits near 0.0% while payout is around 0.0%.

Structure Score

One-glance gauge for the current market-structure regime.

Pillar Radar

Trend, ownership, pressure, and capital rhythm mapped on one wheel.

Position And Float Balance

Shows whether the stock is extended, tightly held, or carrying capital-return support.

Dividend Cadence Tape

Historical dividend-event counts help reveal how dependable the income rhythm has been.

Dividend Cadence Ledger

Annual
Year Dividend Count Context
2016 1 Full year

Structure Facts

Live Snapshot
Implied Spot
14.80
derived from market cap / shares
52W High
16.40
upper auction edge
52W Low
10.75
lower auction edge
Beta
0.08
volatility character
Shares Out
635.4M
fully diluted count
Shares Float
0
tradable register
Shares Short
0
borrowed stock
Short Ratio
0.0x
days-to-cover style read
Ex-Dividend
2016-05-19
-3622 day(s) to ex-date
Dividend Pay
-
payment date not supplied
Last Split
-
split date not supplied

Capital Radar

Capital Regime
—
Building signal blend...
Smart Money Tilt
—
Public vs institutions
Target Conviction
—
Broker coverage pulse
Insider Pressure
—
Director + TR1 flow
Last Held Position
-
Public Hands
-
Institutions
19.2427
Institutions As Of
2025-10-14
Avg Broker Target
-
Upside Vs Price
-
Purchase Director Dealing
1
Sale Director Dealing
2
Purchase TR1
1
Sale TR1
6
Broker Coverage Rows
0
Institution Holders Tracked
3
Public Vs Institutional Ownership (3D)
Top Institution Holders (Latest Per Holder)
Director Dealing Sentiment Flow
Broker Target Bias
Signal: Pending
Capital Momentum Matrix
Broker Targets Vs Price
Aggregated Institution Weight By Holder

Short Data - Last 30 Days

Nexus Pulse Engine

Overall Buy/Sell/Hold
Signal: Pending
Technical Composite
Signal: Pending
Financial Composite
Signal: Pending
Fundamental Composite
Signal: Pending
Short Pressure
Signal: Pending
Momentum Bias
Signal: Pending

Volatility Lab

ATR(14)
Realized Vol (20d)
Volume Spike Z

AI Charts

News And Alerts First

The alert tape opens the door for INOV, and AI Charts sits just below.

Start with the headline flow and live catalyst tape first. Then move straight into AI Charts below for price reaction, AI targets, chart structure and catalyst beacons while the news context is still hot.
Live Tape Data 2026-03-31 AI Charts Below
Read the alert tape first, then move into AI Charts below. Use AI Expand on any catalyst card to open the AI explanation and results tables instantly.
1 Today
Catalyst Pulse
Schroders Capital Global Innovation Trust plc - INOV has fresh news flow live now, so the tape is framing the chart workspace below.
AI Charts Studio
INOV Price History
Live structure, automated forecasts, technical overlays and catalyst beacons in one chart workspace.
30 Day View Window 30D Data 2026-03-31 Open Preview Studio Brief
Chart Intelligence Suite
Swipe the timeframe, call the overlays, and keep the AI signal stack fused into one chart cockpit.
The mobile chart console is now framed as one connected surface so forecasting, structure, catalyst beacons and chart tools all sit inside the price workspace.

Automated signalling scans momentum shifts, crossovers and volatility breaks in real time. Automated AI forecasts map best, average and worst simulation paths forward, predictive MACD extends the momentum story, and catalyst beacons pin market-moving headlines directly onto price action so users can connect news, signals and structure without leaving the chart.

Automated Signalling Automated AI Forecasts Predictive MACD Catalyst Beacons Live Price Structure
Desk Snapshot Member Login
Indicators0
Technicals0
AI Forecast 5.62%
RSI Gauge
Price Change
AI Forecast